Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness-Reference-Cited by-同舟云学术

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness

Published:2012-06-13 Issue:3 Volume:61 Page:350-364
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Dhakal Hari Prasad,Naume Bjørn,Synnestvedt Marit,Borgen Elin,Kaaresen Rolf,Schlichting Ellen,Wiedswang Gro,Bassarova Assia,Holm Ruth,Giercksky Karl-Erik,Nesland Jahn M

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2012.04223.x/fullpdf

Reference48 articles.

1. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma;Weidner;J. Natl Cancer Inst.,1992

2. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis;Fox;J. Pathol.,1995

3. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients;Hansen;Clin. Cancer Res.,2000

4. The biology of VEGF and its receptors;Ferrara;Nat. Med.,2003

5. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer;Bando;Br. J. Cancer,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenic and anti‐angiogenic factors during the post‐hatching growth of the quail (Coturnix coturnix japonica) spleen;The Anatomical Record;2024-04-16

2. Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate‑1 risk patients with myelodysplastic syndromes;Oncology Letters;2023-01-26

3. A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma;BMC Medicine;2022-12-08

4. Synthesis, anti-cancer activity, gene expression and docking stimulation of 2-thioxoimidazolidin-4-one derivatives;Journal of Molecular Structure;2022-10

5. Serum levels of VEGF-A, sVEGFR-2 and galectin-3 do not correlate with clinical stage, tumor size, or effectiveness of perioperative chemotherapy in patients with non-metastatic breast cancer;Annales Academiae Medicae Silesiensis;2022-09-29